Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 58Breast Neoplasms 54Lymphoma 52Multiple Myeloma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Leukemia 48Lymphoma, Non-Hodgkin 46Melanoma 43Lymphoma, Large B-Cell, Diffuse 41Leukemia, Lymphocytic, Chronic, B-Cell 40Myelodysplastic Syndromes 39Lymphoma, Follicular 29Burkitt Lymphoma 25Hodgkin Disease 24Neoplasm Metastasis 22Recurrence 21Neoplasms 21Lymphoma, Mantle-Cell 20Lymphoma, B-Cell, Marginal Zone 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Ovarian Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Primary Myelofibrosis 14Neoplasms, Plasma Cell 14Myeloproliferative Disorders 14Lymphoma, B-Cell 14Hematologic Neoplasms 14Leukemia, Myelomonocytic, Chronic 13Carcinoma, Renal Cell 13Triple Negative Breast Neoplasms 12

Interventions

Dexamethasone 6fosaprepitant 4Calcium Dobesilate 4Aprepitant 4dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Palonosetron 2Ondansetron 2Granisetron 2Cisplatin 2dolasetron 1casopitant 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Neoadjuvant Therapy 1Methadone 1Lorazepam 1Interviews as Topic 1Immunoenzyme Techniques 1Esomeprazole 1Diphenhydramine 1Cyproheptadine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Vomiting × Cyclophosphamide × Clear all
NCT00334646 2017-11-17

Cyclophosphamide Drug Interaction Study In Cancer Patients

GlaxoSmithKline

Phase 1 Terminated
25 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡